Press Releases
-
Mammoth Biosciences Announces Nomination of MB-111 as First Development Candidate and Appoints Genetic Medicines Veteran Bob D. Brown to Board of Directors
Business WireLearn More -
Mammoth Biosciences to Present Preclinical Data on In Vivo Gene Editing of Skeletal Muscle in Non-Human Primates with an Ultracompact CRISPR System at ASGCT 2025
Business WireLearn More -
Mammoth Biosciences Announces New Results on NanoCas – the First Efficient Ultracompact Extrahepatic Gene Editor
Business WireLearn More -
Mammoth Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
Business WireLearn More -
Mammoth Biosciences to Present at Annual Meeting of the American Society of Gene & Cell Therapy
Learn More -
Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases
Learn More -
Mammoth Biosciences to Present at 41st Annual J.P. Morgan Healthcare Conference
Business WireLearn More -
Mammoth Biosciences Announces Appointment of Phil Tinmouth, Siang Chin to Key Leadership Roles
Business WireLearn More -
Mammoth Biosciences Named to Fast Company’s 2022 List of the Next Big Things in Tech
Business WireLearn More -